SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-20-000026
Filing Date
2020-11-06
Accepted
2020-11-06 16:19:12
Documents
103
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-20200930.htm   iXBRL 10-Q 2709419
2 EX-10.1 amrx-2020093010xqexx101.htm EX-10.1 14665
3 EX-31.1 amrx-2020093010xqexx311.htm EX-31.1 12291
4 EX-31.2 amrx-2020093010xqexx312.htm EX-31.2 12418
5 EX-31.3 amrx-2020093010xqexx313.htm EX-31.3 12477
6 EX-32.1 amrx-2020093010xqexx321.htm EX-32.1 7481
7 EX-32.2 amrx-2020093010xqexx322.htm EX-32.2 7426
8 EX-32.3 amrx-2020093010xqexx323.htm EX-32.3 7508
  Complete submission text file 0001723128-20-000026.txt   13215110

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20200930.xsd EX-101.SCH 99692
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20200930_cal.xml EX-101.CAL 130817
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20200930_def.xml EX-101.DEF 585525
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20200930_lab.xml EX-101.LAB 1017875
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20200930_pre.xml EX-101.PRE 694364
14 EXTRACTED XBRL INSTANCE DOCUMENT amrx-20200930_htm.xml XML 2554804
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 201294667
SIC: 2834 Pharmaceutical Preparations